The emergence of antibiotic resistance and the declining drug effectiveness make it imperative to identify potential drug candidates. This study aims to synthesize hydroxyxanthone derivatives as antibacterial candidates. Activity tests were carried out in vitro using Staphylococcus aureus and Escherichia coli, and in silico using molecular docking. Sulfonated hydroxyxanthone derivatives (2a and 2b) were synthesized from 1,3,7- and 1,3,6-trihydroxyxanthones (1a and 1b) through the sulfonation method, yielding 41% and 44%, respectively. The compounds showed greater efficacy against Escherichia coli, with maximum inhibition zones of 14.33 mm (1a) and 15.00 mm (1b), while the sulfonated compound 2b showed relatively better activity against Staphylococcus aureus with an inhibition zone of 14.00 mm, highlighting the impact of molecular structure on antibacterial performance. Molecular docking analysis against penicillin-binding protein 1A (PBP1A) revealed that sulfonated compounds (2a and 2b) exhibited the lowest binding affinity (−7.9 kcal/mol), stronger than the native ligand (penicillin G, -7.4 kcal/mol) and the positive control (amoxicillin, −7.7 kcal/mol), with key interactions with residues Ser487, Thr670, and Thr672, indicating high complex stability and potential inhibitory activity against PBP1A.
Copyrights © 2026